![Anna Berkenblit](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Anna Berkenblit
Direktör/Styrelseledamot på
SURROZEN, INC.
Förmögenhet: 51 549 $ per 2026-08-31
Profil
Anna Berkenblit currently serves as Director at Surrozen Operating, Inc. since 2019, Independent Director at Surrozen, Inc. since 2018, Director at Nested Therapeutics, Inc., and Chief Scientific & Medical Officer at Pancreatic Cancer Action Network, Inc. Former roles include Chief Medical Officer & Senior Vice President at ImmunoGen, Inc. from 2019 to 2023, Vice President at Pfizer Inc. from 2007 to 2011, Vice President & Head-Clinical Research at AVEO Pharmaceuticals, Inc. from 2011 to 2013, and Senior Vice President-Clinical Development at H3 Biomedicine, Inc. from 2013 to 2015.
Education includes graduate degrees from Harvard University and Massachusetts Institute of Technology, an undergraduate degree from Yale University, and a doctorate from Harvard Medical School.
Kända innehav i offentliga företag
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
SURROZEN INC 0,02 % | 2026-05-13 | 2 341 ( 0,02 % ) | 51 549 $ | 2026-08-31 |
Aktiva positioner av Anna Berkenblit
| Företag | Position | Start |
|---|---|---|
| SURROZEN, INC. | Direktör/Styrelseledamot | 2018-08-01 |
Surrozen Operating, Inc.
 Surrozen Operating, Inc. BiotechnologyHealth Technology Discovers and develops novel regenerative medicines | Direktör/Styrelseledamot | 2019-03-14 |
Nested Therapeutics, Inc.
 Nested Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a drug discovery biotechnology company | Direktör/Styrelseledamot | - |
Pancreatic Cancer Action Network, Inc.
 Pancreatic Cancer Action Network, Inc. Medical/Nursing ServicesHealth Services Operates a charity which focuses on the early diagnosis of pancreatic cancer | Teknisk/Vetenskaplig/F&U Direktör | - |
Tidigare kända positioner av Anna Berkenblit
| Företag | Position | Slut |
|---|---|---|
| IMMUNOGEN, INC. | Teknisk/Vetenskaplig/F&U Direktör | 2023-08-31 |
H3 Biomedicine, Inc.
 H3 Biomedicine, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in discovery and development of genomic drugs | Företagsledare/Principal | 2015-01-01 |
| AVEO PHARMACEUTICALS, INC. | Teknisk/Vetenskaplig/F&U Direktör | 2013-01-01 |
| PFIZER INC. | Företagsledare/Principal | 2011-09-01 |
Anna Berkenblits utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
70
Första gradens relationer
12
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 12 |
|---|---|
ImmunoGen, Inc.
 ImmunoGen, Inc. BiotechnologyHealth Technology Develops anticancer therapeutics | Health Technology |
Pfizer Inc.
 Pfizer Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery, development, manufacturing, marketing, sale and distribution of biopharmaceutical products & ingredients | Health Technology |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Massachusetts Institute of Technology
 Massachusetts Institute of Technology Finance/Rental/LeasingFinance Functions as a College/University | Finance |
Yale University
 Yale University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
AVEO Pharmaceuticals, Inc.
 AVEO Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Researches and develops cancer therapeutics | Health Technology |
Harvard Medical School
 Harvard Medical School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Pancreatic Cancer Action Network, Inc.
Pancreatic Cancer Action Network, Inc. Medical/Nursing ServicesHealth Services Operates a charity which focuses on the early diagnosis of pancreatic cancer | Health Services |
H3 Biomedicine, Inc.
H3 Biomedicine, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in discovery and development of genomic drugs | Commercial Services |
Surrozen Operating, Inc.
Surrozen Operating, Inc. BiotechnologyHealth Technology Discovers and develops novel regenerative medicines | Health Technology |
Surrozen, Inc.
 Surrozen, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that discovering and developing drug candidates | Health Technology |
Nested Therapeutics, Inc.
Nested Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a drug discovery biotechnology company | Commercial Services |
